1Filipowicz W,Bhattacharyya SN,Sonenberg N.Mechanisms of posttranscriptional regulation by microRNAs:are the answers in sight?Nat Rev Genet,2008,9:102 -114.
2Zhao Y,Samal E,Srivastava D.Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis.Nature,2005,436:214-220.
3Ajay SS,Athey BD,Lee I.Unified translation repression mechanism for microRNAs and upstream AUGs.BMC Genomics,2010,11:155.
4Thum T,Gross C,Fiedler J,et al.MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts.Nature,2008,456:980-984.
5Roy S,Khanna S,Hussain SR,et al.MicroRNA expression in response to murine myocardial infarction:miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue.Cardiovasc Res,2009,82:21-29.
6van Rooij E,Sutherland LB,Thatcher JE,et al.Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis.Proc Natl Acad Sci USA,2008,105:13027-13032.
7Yang B,Lin H,Xiao J,et al.The muscle-specific microRNA miR-l regulates cardiac arrhythmogenic potential by targeting GJAI and KCNJ2.Nat Med,2007,13:486-491.
8Lu Y,Zhang Y,Shan H,et al.MicroRNA-1 downregulation by prolranolol in a rat model of myocardial infarction:a new mechanism for ischaemic cardioprotection.Cardiovasc Res,2009,84:434-441.
9Bostjancic E,Zidar N,Stajner D,et al.MicroRNA miR-1 is up-regulated in remote myocardium in patients with Myocardial Infarction.Folia Biol(Praha),2010,56:27-31.
10Xiao J,Luo X,Lin H,et al.MicroRNA miR-133 represses HERG K'channel expression contributing to QT prolongation in diabetic hearts.Journal of Bioligical Chemistry,2007,282:12363-12367.
4Stenvang J, Petri A. Lindow M. et al. Inhibition of mieroRNA function by antimiR oligomteleotides. Silenee, 2012.3: 1.
5Bernardp BC. Gao XM, Winbanks CE, el al. Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart fimction. Pric Natl Acad Sci USA. 2012, 109: 17615-17620.
6Narolska NA, Eiras S. Van Loon RB. el al. Myosin heavy chain composition and the economy of contraction in healthy and diseased human myoeardium. J Muscle Res Cell Motil, 2005, 26: 39-48.
7Lowes BD, C, ilherl EM. Abraham WT, et al. Myo,-ardial gene expressiCul in dilated cardiomyopathy treated wilh β -blocking agents. N Engl J Med, 2002, 346: 1357-1365.
8Small EM, Olsnn EN. Pervasive roles of microRNAs in eardiovaseular biology. Nature. 2011. 469: 336-342.
9Bernardo BC, Charchar FJ, Lin RCY, et al. A microRNA guide for clinicians and basic scientists: Background and experimental techniques. Hearl Lung Cite, 2012.21: 131-142.
10Cubbon RM, Gale CP, Kearney LC, et al. Changing characteristics and mode of death associated with chronic heart failure caused by left ventrieular systolic dysfunction: a study across therapeutic eras. Circ Heart Fail, 2011, 4: 396-403.
